Harmony Biosciences
HRMY
HRMY
276 hedge funds and large institutions have $1.62B invested in Harmony Biosciences in 2025 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 126 increasing their positions, 68 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1.79% more ownership
Funds ownership: 87.44% → 89.23% (+1.8%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $1.66B → $1.62B (-$43.1M)
Holders
276
Holding in Top 10
3
Calls
$10.5M
Puts
$2.26M
Top Buyers
| 1 | +$19.4M | |
| 2 | +$16.1M | |
| 3 | +$13M | |
| 4 |
Goldman Sachs
New York
|
+$11.9M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$11.3M |
Top Sellers
| 1 | -$28.6M | |
| 2 | -$20.7M | |
| 3 | -$15M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$10.3M |
| 5 |
JPMorgan Chase & Co
New York
|
-$9.19M |
